Turn Bio commences bone marrow rejuvenation study

Turn Bio commences bone marrow rejuvenation study

By Danny Sullivan – Longevity.Technology Methuselah Foundation backs mouse study exploring epigenetic reprogramming therapy to address age-related decline in bone marrow function. Cell rejuvenation company Turn Biotechnologies has announced the launch of a new...